Open AccessCorrection: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Author(s) -
Rebecca C. Arend,
Angelina I. Londoño-Joshi,
Abhishek Gangrade,
Ashwini A. Katre,
Chandrika Kurpad,
Yonghe Li,
Rajeev S. Samant,
PuiKai Li,
Charles N. Landen,
Eddy S. Yang,
Bertha Hidalgo,
Ronald D. Alvarez,
J. Michael Straughn,
Andres Forero,
Donald J. Buchsbaum
Publication year - 2018
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.25151
Subject(s) - niclosamide , wnt signaling pathway , cancer research , pi3k/akt/mtor pathway , medicine , ovarian cancer , oncology , signal transduction , cancer , biology , microbiology and biotechnology , ecology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom